Vizora日本語

Industry map

Healthcare & Consumer Goods industry map

Who earns the money in Healthcare & Consumer Goods, and who keeps it. When a company spans several industries, only the relevant segment is counted.

FY2025 · 245 companies · ¥21.4T

Industry map

Companies ordered by revenue, connected by ownership (major shareholders). Arrows point from the shareholder to the investee.

Industry size (revenue)
¥21.4T

YoY +5.3%

Companies
245
Avg. salary（parent only）
¥6.8M

Avg. age 42.0

Industry weather
Sunny

Operating income +14.9%

Kao[4452]

Hygiene living care business + 4 more

#1
Revenue
¥1.72T▲2.3%
Operating income
¥172.2B▲17.8%

Margin 10.0%

Whole company: Revenue ¥1.69T · Net income ¥120.1B

Avg. salary ¥8.7M · 40.6（parent only）

Shiseido[4911]

China and travel retail business + 4 more

#2
Revenue
¥958.6B▼1.7%
Operating income
¥101B▲5.0%

Margin 10.5%

Whole company: Revenue ¥970B · Net income -¥40.7B

Avg. salary ¥7.1M · 39.3（parent only）

Oji Holdings[3861]

Household and Industrial Materials

#3
Revenue
¥874.1B▲3.2%
Operating income
¥19.7B▲7.5%

Margin 2.3%

Whole company: Revenue ¥1.86T · Net income ¥55.6B

Avg. salary ¥8.5M · 44.5（parent only）

Unicharm[8113]

Personal care

#4
Revenue
¥774.4B▼6.3%
Operating income
¥83.2B▼25.0%

Margin 10.7%

Whole company: Revenue ¥945.3B · Net income ¥65.2B

Avg. salary ¥8.8M · 40.7（parent only）

Kirin Holdings[2503]

Pharmaceuticals + 1 more

#5
Revenue
¥747.9B▲11.5%
Operating income
¥113.4B▲40.1%

Margin 15.2%

Whole company: Revenue ¥2.43T · Net income ¥147.5B

Avg. salary ¥10M · 41.6（parent only）

Kyowa Kirin[4151]

#11▼
Revenue
¥496.8B▲0.3%
Operating income
—

Avg. salary ¥9.9M · 42.4（parent only）

  • Kirin Holdings owns 55.2%

Asahi Kasei[3407]

Health Care

#6
Revenue
¥664.1B▲7.8%
Operating income
¥83.5B▲30.3%

Margin 12.6%

Whole company: Revenue ¥3.07T · Net income ¥158.8B

Avg. salary ¥8.5M · 41.9（parent only）

  • Teijin・Joint venture

Bandai Namco Holdings[7832]

Toys and Hobby Business

#7
Revenue
¥646.2B▲12.4%
Operating income
¥126.9B▲24.2%

Margin 19.6%

Whole company: Revenue ¥1.35T · Net income ¥140.7B

Avg. salary ¥9.8M · 44.6（parent only）

Rohto Pharmaceutical[4527]

Japan + 5 more

#8
Revenue
¥634.7B▲11.2%
Operating income
¥77.1B▲8.5%

Margin 12.1%

Whole company: Revenue ¥343.7B · Net income ¥34.2B

Avg. salary ¥8.5M · 42.1（parent only）

  • Euglena・Capital alliance

Hoya[7741]

Life Care

#9
Revenue
¥590.7B▲7.2%
Operating income
—

Whole company: Revenue ¥947.7B · Net income ¥253.1B

Avg. salary ¥9.7M · 47.6（parent only）

Sumitomo Chemical[4005]

Sumitomo Pharma + 1 more

#10▲
Revenue
¥510.5B▲11.0%
Operating income
¥111.3B▲183.1%

Margin 21.8%

Whole company: Revenue ¥2.33T · Net income ¥60.9B

Avg. salary ¥9.6M · 42.4（parent only）

Nippon Paper Industries[3863]

Lifestyle

#12▲
Revenue
¥482B▲5.3%
Operating income
¥7.17BBack to profit

Margin 1.5%

Whole company: Revenue ¥1.19T · Net income ¥11.7B

Avg. salary ¥6.9M · 43.0（parent only）

※ Card revenue and operating income cover only the segment in this industry; “Whole company” shows consolidated revenue and net income.

Other companies: Askul · Sumitomo Pharma · Otsuka · KOSE Holdings · Lion · Abc-Mart · Ajinomoto · Kokuyo · Kobayashi Pharmaceutical · Daio Paper · Chugai Mining · Towa Pharmaceutical · Tomy Company · Casio Computer · Meiji Holdings · Seiko Group · Sawai Group Holdings · Citizen Watch · Seiko Epson · Sanrio Company · Tsumura & · Happinet · Okamura · Pola Orbis Holdings · Pilot · H.U. Group Holdings · Japan Airport Terminal · BML · Earth · Teijin · Nitto Denko · AGC · PHC Holdings · KYORIN Pharmaceutical · Mochida Pharmaceutical · Qol Holdings · Itoki · Jins Holdings · Zeria Pharmceutical · Mitsubishi Pencil …+193

The weather is derived mechanically from year-over-year totals of revenue and operating income (both up = sunny, both down = rainy).

Switch years to see how the map shifts

Who earns the money

Area = revenue from businesses in this industry. Color = operating margin.

LossHigh margin(middle = 0% margin)

Who makes a profit

Across = revenue (log scale), up = operating margin, bubble size = operating income.

Ranking and momentum

RankCompany (business)RevenueShareOp. marginCAGRFCF*
1KaoHygiene living care business + 4 more¥1.72T8.0%10.0%+63.6%¥128.8B
2ShiseidoChina and travel retail business + 4 more¥958.6B4.5%10.5%+14.3%¥65.5B
3Oji HoldingsHousehold and Industrial Materials¥874.1B4.1%2.3%+8.1%¥20.9B
4UnicharmPersonal care¥774.4B3.6%10.7%+3.6%¥102.8B
5Kirin HoldingsPharmaceuticals + 1 more¥747.9B3.5%15.2%+20.8%¥119.8B
6Asahi KaseiHealth Care¥664.1B3.1%12.6%+12.4%¥92.1B
7Bandai Namco HoldingsToys and Hobby Business¥646.2B3.0%19.6%+15.6%¥118.9B
8Rohto PharmaceuticalJapan + 5 more¥634.7B3.0%12.1%+14.1%¥21.5B
9HoyaLife Care¥590.7B2.8%—+9.7%¥221.9B
10▲2Sumitomo ChemicalSumitomo Pharma + 1 more¥510.5B2.4%21.8%——
11▼1Kyowa Kirin¥496.8B2.3%—+9.0%¥13.1B
12▲1Nippon Paper IndustriesLifestyle¥482B2.3%1.5%+5.7%¥20.7B
13▼2AskulE-commerce¥472.2B2.2%3.0%+3.4%-¥2.54B
14Sumitomo PharmaNorth America + 2 more¥453.3B2.1%21.5%—¥64.4B
15▲1OtsukaService and support business¥419.9B2.0%7.0%+6.3%¥72.2B
16▼1KOSE HoldingsCosmetics Business + 2 more¥391.3B1.8%7.5%+11.0%-¥10.3B
17LionGeneral-use consumable products business + 1 more¥381.9B1.8%—+3.9%¥21.3B
18Abc-MartDomestic + 1 more¥378.6B1.8%16.8%+11.6%¥27.5B
19▲1AjinomotoHealthcare and others¥341.5B1.6%—+8.0%¥134.8B
20▲1KokuyoFurniture businesses + 2 more¥336B1.6%11.5%+2.7%¥3.1B
21▼2Kobayashi PharmaceuticalDomestic Business + 3 more¥330.1B1.5%8.9%+3.2%¥11.6B
22Daio PaperHome and Personal Care¥298.9B1.4%2.7%+3.8%¥33.3B
23▲12Chugai MiningPrecious metal business + 1 more¥280.9B1.3%1.1%+54.0%¥1.92B
24▼1Towa PharmaceuticalDomestic + 1 more¥273.7B1.3%10.1%+13.4%¥6.3B
25▼1Tomy CompanyJapan + 4 more¥270.5B1.3%11.4%+13.1%¥12.4B
26▼1Casio ComputerWatch + 1 more¥267B1.2%11.4%+3.4%¥13.6B
27▼1Meiji HoldingsPharmaceuticals¥232.2B1.1%13.1%+5.5%-¥47.2B
28▼1Seiko GroupEmotional Value Solutions Business¥218B1.0%13.1%+10.2%¥22.8B
29newSawai Group Holdings¥201.7B0.9%7.9%+1.0%-¥17B
30▼1Citizen WatchWatches and Clocks¥197.1B0.9%12.7%+10.7%¥15B
31▼1Seiko EpsonManufacturing-related and Wearables¥196.9B0.9%5.5%+1.9%¥51.5B
32▲6Sanrio CompanyJapan + 4 more¥194.1B0.9%42.0%+38.5%¥46.9B
33▼5Tsumura &¥192.6B0.9%18.3%+10.4%-¥9.66B
34▼3HappinetToy business¥192.4B0.9%5.9%+16.2%¥15.2B
35▼3OkamuraOffice Furniture business¥191.9B0.9%11.8%+8.1%¥16.4B
36▼2Pola Orbis HoldingsBeauty care¥164.1B0.8%9.7%-1.5%¥11.9B
37▼4PilotAmerica + 4 more¥163.8B0.8%17.3%+5.1%¥5.48B
38▼2H.U. Group HoldingsClinical Lab Testing Business¥157.3B0.7%0.0%-3.3%¥16.7B
39▼2Japan Airport TerminalMerchandise Sales¥154.1B0.7%17.8%+84.9%¥33.9B
40▼1BML¥150.3B0.7%6.9%-5.2%¥10.6B
41▼1EarthHousehold products business¥145.3B0.7%4.5%-4.8%¥6.62B
42TeijinHelthcare¥138.6B0.6%9.7%—¥38.7B
43▲2Nitto DenkoHuman life¥137.2B0.6%-3.7%+13.1%¥95.6B
44▼3AGCLifescience¥129.4B0.6%-17.2%—¥64.9B
45▼1PHC HoldingsHealthcare Solutions¥128.4B0.6%4.9%-1.5%¥33.4B
46▼3KYORIN Pharmaceutical¥126.3B0.6%2.8%+4.6%¥2.4B
47▼1Mochida Pharmaceutical¥117B0.5%8.7%+1.5%-¥10B
48Qol HoldingsPharmaceutical business + 1 more¥113.3B0.5%7.8%—¥10.6B
49▼2ItokiWorkplace business¥111.5B0.5%9.9%+8.5%¥2.92B
50▲4Jins HoldingsDomestic eyewear business + 1 more¥97.2B0.5%12.4%+11.1%¥5.1B

Showing the top 50. See all 245 in the list below

* FCF is company-wide (not disclosed by segment). CAGR covers the available years, up to five.

How they make money differently

Where each company's ¥100 of sales goes, and how much it keeps (company-wide).

  • Cost of sales
  • Operating costs
  • SG&A
  • Other
  • Operating profit

Showing the 25 largest companies by revenue.

Ownership links

From the major-shareholder section of annual securities reports.

The company on each card is a major shareholder of the companies listed under it (latest 'major shareholders' disclosure). 50%+ is labelled subsidiary and 20%+ affiliate, based on ownership alone. Stakes under 3% are omitted. Showing up to 24 shareholder cards.

Compare the leaders side by side

Kao × Shiseido × Oji Holdings × Unicharm

All companies in Healthcare & Consumer Goods (by revenue)

All 263 companies in this industry, ranked by revenue in each company's latest fiscal year. For companies that belong through one business segment, the figure is that segment's revenue.

  1. Takeda Pharmaceutical¥4.26T
  2. Otsuka Holdings¥2.02T
  3. Kao¥1.72T · 10.0%
  4. Astellas Pharma¥1.6T
  5. Daiichi Sankyo¥1.6T
  6. Chugai Pharmaceutical¥1.11T
  7. Shiseido¥958.6B · 10.5%
  8. Oji Holdings¥874.1B · 2.3%
  9. Unicharm¥774.4B · 10.7%
  10. Kirin Holdings¥747.9B · 15.2%
  11. Eisai¥741.8B · 7.2%
  12. Asahi Kasei¥664.1B · 12.6%
  13. Bandai Namco Holdings¥646.2B · 19.6%
  14. Rohto Pharmaceutical¥634.7B · 12.1%
  15. Hoya¥590.7B
  16. Sumitomo Chemical¥510.5B · 21.8%
  17. ONO Pharmaceutical¥502.7B
  18. Kyowa Kirin¥496.8B
  19. Nippon Paper Industries¥482B · 1.5%
  20. Sumitomo Pharma¥453.3B · 21.5%
  21. Otsuka¥419.9B · 7.0%
  22. Shionogi &¥410.1B
  23. Askul¥393.1B · -4.1%
  24. KOSE Holdings¥391.3B · 7.5%
  25. Lion¥381.9B
  26. Abc-Mart¥378.6B · 16.8%
  27. Ajinomoto¥341.5B
  28. Kokuyo¥336B · 11.5%
  29. Kobayashi Pharmaceutical¥330.1B · 8.9%
  30. Santen Pharmaceutical¥302B
  31. Daio Paper¥298.9B · 2.7%
  32. Chugai Mining¥280.9B · 1.1%
  33. Towa Pharmaceutical¥273.7B · 10.1%
  34. Tomy Company¥270.5B · 11.4%
  35. Casio Computer¥267B · 11.4%
  36. Meiji Holdings¥232.2B · 13.1%
  37. Seiko Group¥218B · 13.1%
  38. Sawai Group Holdings¥201.7B · 7.9%
  39. Citizen Watch¥197.1B · 12.7%
  40. Seiko Epson¥196.9B · 5.5%
  41. Sanrio Company¥194.1B · 42.0%
  42. Tsumura &¥192.6B · 18.3%
  43. Happinet¥192.4B · 5.9%
  44. Okamura¥191.9B · 11.8%
  45. Pola Orbis Holdings¥164.1B · 9.7%
  46. Pilot¥163.8B · 17.3%
  47. H.U. Group Holdings¥157.3B · 0.0%
  48. Japan Airport Terminal¥154.1B · 17.8%
  49. BML¥150.3B · 6.9%
  50. Nippon Shinyaku¥148.3B
  51. Earth¥145.3B · 4.5%
  52. Teijin¥138.6B · 9.7%
  53. Nitto Denko¥137.2B · -3.7%
  54. AGC¥129.4B · -17.2%
  55. PHC Holdings¥128.4B · 4.9%
  56. KYORIN Pharmaceutical¥126.3B · 2.8%
  57. Mochida Pharmaceutical¥117B · 8.7%
  58. Qol Holdings¥113.3B · 7.8%
  59. Itoki¥111.5B · 9.9%
  60. Jins Holdings¥97.2B · 12.4%
  61. Zeria Pharmceutical¥89B · 20.8%
  62. Mitsubishi Pencil¥87.4B · 10.8%
  63. Kaneka¥83B · 17.9%
  64. Chiyoda¥81.4B · 1.3%
  65. Nipro¥81.1B · 14.9%
  66. Takara Holdings¥80.6B · -11.6%
  67. Kissei Pharmaceutical¥78B · -5.8%
  68. Fumakillalimited¥77.4B · 2.0%
  69. Toho¥75.3B · 23.0%
  70. Kaken Pharmaceutial¥74.3B · -3.1%
  71. Nippon Kayaku¥73B · 13.3%
  72. ASKA Pharmaceutical Holdings¥71.1B · 10.6%
  73. LEC¥68.3B · 6.1%
  74. Fuso Pharmaceutical Industries¥62.3B · 4.2%
  75. noevir holdings¥62.1B · 21.4%
  76. Uchida Yoko¥59.4B · 3.3%
  77. Astena Holdings¥57.1B · 5.1%
  78. Milbon¥52.9B · 10.7%
  79. Toray Industries¥52.4B · -0.2%
  80. Fuji Pharma¥51.7B · 9.7%
  81. Sac's BAR Holdings¥51.3B · 6.2%
  82. Daito Pharmaceutical¥50.6B · 7.2%
  83. Nichiban¥50.5B · 14.2%
  84. Intermestic¥50.2B · 11.9%
  85. NOF¥49.9B · 31.7%
  86. Bushiroad¥49.9B · 9.4%
  87. I-ne¥49B · 14.6%
  88. S.T.¥48.5B · 4.1%
  89. Euglena¥47B · 11.7%
  90. PeptiDream¥46.7B · 45.4%
  91. Yondoshi Holdings¥45.3B · 6.3%
  92. Shinnihonseiyaku¥41.1B · 11.6%
  93. Denka¥40.5B · 15.4%
  94. JCR Pharmaceuticals¥40.3B · 1.4%
  95. Alfresa Holdings¥37.2B · 3.2%
  96. Lion Office Products¥37B · 3.2%
  97. Suzuken¥36.6B · 5.8%
  98. Taiyo Holdings¥36.5B · 13.9%
  99. Tsutsumi Jewelry¥35.2B · 14.9%
  100. Toyobo¥34.5B · 0.2%
  101. Nippon Chemiphar¥33.1B · 0.5%
  102. Okamoto Industries¥32B · 23.8%
  103. Estelle Holdings¥31.8B · 3.0%
  104. Shin Nippon Biomedical Laboratories¥31.3B · 9.2%
  105. Nakabayashi¥30.6B · 5.9%
  106. Nagahori¥29.2B · 5.6%
  107. Primo Global Holdings¥28B · 11.2%
  108. Furyu¥27.7B · 8.4%
  109. Mitsui Matsushima Holdings¥27.1B · 9.1%
  110. Falco Holdings¥26.7B · 6.8%
  111. Yakult Honsha¥26B · 5.1%
  112. King JIM¥24.9B · 2.6%
  113. Seikagaku¥24.5B · -6.7%
  114. M3¥24.4B · 21.0%
  115. Square Enix Holdings¥23.6B · 47.7%
  116. NEW ART Holdings¥23.1B · 24.9%
  117. Regal¥22.8B · -1.7%
  118. Shobido¥22.1B · 6.6%
  119. MAX¥21.4B · 16.7%
  120. AFC-HD AMS Life Science¥21.4B · 12.6%
  121. UBE¥20.6B · -6.1%
  122. WA¥20.3B · 15.2%
  123. Tokushu Tokai Paper¥18.8B · 4.3%
  124. Japan Eyewear Holdings¥18.6B · 35.1%
  125. GNI Group¥18.3B · 2.0%
  126. Kotobukiya¥16.8B · 4.6%
  127. Nippon Shikizai¥16.6B · 1.2%
  128. SK Japan¥16.2B · 11.5%
  129. Vitabrid Japan¥15.3B · 6.7%
  130. Aigan¥15.3B · 1.5%
  131. Nicca Chemical¥15.3B · 12.9%
  132. Osaka Soda¥14.6B · 48.9%
  133. ktk¥14.6B · 5.7%
  134. Genda¥14.3B
  135. Nippi¥14.1B · 10.7%
  136. DyDo GROUP HOLDINGS¥13.8B · 3.7%
  137. Axxzia¥13.5B · 3.8%
  138. Takano¥13.4B · 5.7%
  139. Premier Anti-Aging¥12.9B · 3.2%
  140. Nxera Pharma¥12.8B
  141. Inaba Seisakusho¥12.7B · 2.5%
  142. Morishita Jintan¥12.7B · 5.5%
  143. Intage Holdings¥12.6B · 21.3%
  144. Haba Laboratories¥12.1B · 6.0%
  145. Sanyei¥11.9B · 7.2%
  146. Hiraki¥11.9B · 0.8%
  147. Noritsu Koki¥11.7B · 23.6%
  148. Katakura Industries¥11.7B · 8.2%
  149. Belluna¥11.4B · 6.4%
  150. House of Rose¥10.3B · -1.0%
  151. Liberta¥10B · 1.3%
  152. Wakamoto Pharmaceutical¥9.71B · 1.9%
  153. Cota¥9.6B · 20.8%
  154. Verite¥9.44B · 7.4%
  155. Festaria Holdings¥9.4B · 3.1%
  156. C'bon Cosmetics¥9.27B · 2.7%
  157. KOA Shoji Holdings¥8.96B · 23.7%
  158. shoei¥8.94B · 5.1%
  159. Achilles¥8.93B · -3.6%
  160. happiness and d¥8.84B · -4.6%
  161. Lihit LAB.¥8.68B · 2.3%
  162. Hobonichi¥8.68B · 7.1%
  163. Linical¥8.67B · -23.9%
  164. Sakai Chemical Industry¥8.39B · -0.6%
  165. Fujicopian¥8.04B
  166. Toei Animation¥7.9B · 9.3%
  167. Sekido¥7.86B · -1.6%
  168. Capcom¥7.65B · 47.6%
  169. Rhythm¥7.58B · -1.0%
  170. Nippon Fine Chemical¥7.21B · 7.9%
  171. K-uno¥7B · 1.5%
  172. WDB Holdings¥6.76B · 15.5%
  173. Nihon Seimitsu¥6.73B · 2.8%
  174. seiren¥6.68B · 11.1%
  175. NAC Co .¥6.64B · 3.7%
  176. Kidswell Bio¥6.59B · -2.1%
  177. Taiko Pharmaceutical¥6.39B · 20.6%
  178. Barcos¥5.25B · 7.3%
  179. Nissan Chemical¥5.13B · 26.3%
  180. WDB coco¥4.82B · 19.9%
  181. Kurogane Kosakusho¥4.72B · 6.3%
  182. Sagami Rubber Industries¥4.68B · 16.3%
  183. Toho Lamac¥4.45B · -3.0%
  184. Kohsai¥4.24B · 4.2%
  185. AuBEX¥4.24B · 18.1%
  186. ReproCELL¥4.19B · 3.6%
  187. Nihon Nohyaku¥4.17B · 18.4%
  188. Muscat Group¥4.13B · -9.7%
  189. Studio Atao¥4.13B · 5.8%
  190. Muromachi Chemicals¥3.99B · 15.9%
  191. Lipps CO,.¥3.97B · 19.8%
  192. Adjuvant Holdings¥3.81B · 4.5%
  193. Crossfor¥3.76B · 1.5%
  194. Bunkeido¥3.75B · 11.0%
  195. CellSource¥3.71B · 4.5%
  196. Nihon ISK¥3.68B · 11.9%
  197. Meito¥3.55B · 22.8%
  198. Jelly Beans Group¥3.52B · 10.7%
  199. Kohjin Bio¥3.51B · 29.2%
  200. Forside¥3.46B · 9.8%
  201. The Sailor Pen¥3.34B · 1.7%
  202. Waqoo¥2.95B · 24.6%
  203. StemCell Institute¥2.81B · 7.2%
  204. Japan Tissue Engineering¥2.73B · 28.8%
  205. Toho Holdings¥2.65B · 10.6%
  206. IVY Cosmetics¥2.64B · 7.4%
  207. Akatsuki¥2.56B · 18.5%
  208. Laxus Technologies¥2.28B · 8.1%
  209. Trans Genic Group¥2.25B · -7.3%
  210. Ateam Holdings¥2.25B · 0.3%
  211. Shofu¥2.23B · -5.1%
  212. T.kawabe &¥2.1B · -7.6%
  213. TOC¥2.03B · 0.6%
  214. 4Cs HD¥1.81B · 20.2%
  215. Tokyo Soir¥1.63B · 5.0%
  216. People¥1.61B · -10.8%
  217. Artra Group¥1.57B · -1.6%
  218. PhoenixBio¥1.57B · 5.3%
  219. Human Metabolome Technologies¥1.42B · 14.8%
  220. SymBio Pharmaceuticals¥1.31B · -339.6%
  221. THE WHY HOW DO Company¥1.25B · 10.4%
  222. Hyper¥1.2B · 10.0%
  223. Chuo Malleable Iron¥1.15B · 4.2%
  224. IG Port¥1.14B · 54.3%
  225. Dream Vision¥1.11B · -6.9%
  226. Soiken Holdings¥1.1B · 5.8%
  227. Asahipen¥1.05B · -6.7%
  228. Fronteo¥1.03B · -1.6%
  229. Vixton¥949M · -26.1%
  230. Heartseed¥873.6M · -118.9%
  231. stream¥823.5M · 3.2%
  232. Wedge Holdings¥816.2M · -11.2%
  233. Medinet¥810.3M · -108.9%
  234. Toabo¥803M · -7.5%
  235. PRISM BioLab¥677.3M · -114.3%
  236. Solasia Pharma¥617M
  237. Chiome Bioscience¥593.3M · 59.9%
  238. Carna Biosciences¥579.1M · -8.8%
  239. UNIVA Oak Holdings¥473.6M · -37.6%
  240. D.Western Therapeutics Institute¥387.6M · -159.9%
  241. Pharma Foods International¥331M · -114.2%
  242. Stella Pharma¥323.4M · -231.6%
  243. Axel Mark¥301.2M · -53.0%
  244. Wel-Dish.¥261.5M · 29.2%
  245. AppBank¥249.5M · -9.9%
  246. Cyfuse Biomedical¥231M · -358.5%
  247. Cuorips¥212.3M · -509.2%
  248. Tsubota Laboratory¥200M · -393.9%
  249. Nano Holdings¥174.5M · -553.6%
  250. TriIs¥164.7M · 15.4%
  251. Perseus Proteomics¥135.5M · -549.8%
  252. Medrx¥128.1M · -735.4%
  253. Hirota Group Holdings¥127.3M · 92.2%
  254. Healios¥121M
  255. Intertrade¥104.7M · -48.8%
  256. Fuji Latex¥86.9M · -59.3%
  257. CellSeed¥83.7M · -989.2%
  258. Kringle Pharma¥72.2M · -1259.4%
  259. Abist¥49.6M · 46.4%
  260. Oncolys BioPharma¥28.5M · -7090.6%
  261. J-Holdings¥6M · -1084.2%
  262. Immuno-Biological Laboratories¥2.7M · -22.7%
  263. BrightPath Biotherapeutics¥1.1M · -102464.1%

Revenue · Op. margin

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image